London Daily

Focus on the big picture.
Saturday, Jul 05, 2025

German expert panel says under-60s who got first AstraZeneca shot should receive DIFFERENT vaccine for second jab

German expert panel says under-60s who got first AstraZeneca shot should receive DIFFERENT vaccine for second jab

A German expert panel has recommended those who received one AstraZeneca jab should take another vaccine as their second dose, since the British jab’s side effects could be more dangerous than taking two different products.

All Germans under 60 “should be given a dose of an mRNA vaccine 12 weeks after the first vaccination instead of the second AstraZeneca … dose,” the German Government’s Standing Committee on Vaccination (STIKO) said in its latest draft recommendation published on Thursday. The jabs produced by Pfizer-BioNTech and Moderna were mentioned as possible substitutes.

“So far, no data are available on the risk of the second vaccination [with AstraZeneca],” the expert panel admits, adding that “scientific evidence” on safety and effectiveness of vaccination with two different jabs is also lacking. Still, STIKO recommended the second option for that age group.

AstraZeneca’s Vaxzevria jab can only be given to those under 60 “at the discretion of the doctor” and after a patient accepts all potential risks, the panel concluded.

The rather unorthodox advice, which implies that millions of people might potentially be forced to rely on a yet-untested vaccination strategy, comes amid serious concerns related to the British-Swedish vaccine’s potential serious side effects.

“At the moment, one can only speculate about the risk of having been vaccinated twice,” Thomas Mertens, the head of STIKO, told Der Spiegel on Thursday referring to the Vaxzevria jab.

"The obvious way out is not to try it at all but to give an mRNA vaccine as an alternative to be on the safe side."


A virologist and the former medical director of the Ulm University Hospital, Mertens also said that the results of animal experiments available so far “show that the immune response is the same” after vaccination with two different shots.

He admitted, though, that the researchers still “have to scientifically clarify” whether the protection would be just as good in humans. He also said that “there will be data on this soon.”

STIKO had announced on Tuesday that Vaxzevria can only be given to over-60s. The decision came after Germany's vaccine regulator, the Paul Ehrlich Institute, disclosed that as of March 29, the country has recorded 31 cases of cerebral sinus vein thrombosis (CSVT), nine of which resulted in death, after people took the Vaxzevria shots. CSVT is a rare form of blood clot that forms in the brain.

Mertens called the regulator’s report a “very clear signal” which STIKO had to react to. The report also suggested that people under 60 appear more likely to be affected by this particular side effect. He also cited the data provided by Norway that suggested the jab provoked CSVT “at a ratio of 1 to 25,000 vaccinations.”

Some 2.8 million Germans already received their first Vaxzevria shot. Only around 2,000 people took the second shot too, according to German media. According to official figures, women under the age of 70 make up two-thirds of those vaccinated with the AstraZeneca drug. Some reports attribute this statistic to a fact that nurses were one of the primary groups to get it.

Earlier, dozens of nations in Europe and beyond temporarily halted the use of the vaccine following the reports of fatal blood clotting. Both the European Medicines Agency (EMA) and the World Health Organization have both said that they consider Vaxzevria safe to use, however, with benefits outweighing the risks of rare side-effects.

Newsletter

Related Articles

0:00
0:00
Close
Elon Musk Founds a Party Following a Poll on X: "You Wanted It – You Got It!"
London Stock Exchange Faces Historic Low in Initial Public Offerings
A new online platform has emerged in the United Kingdom, specifically targeting Muslim men seeking virgin brides
Trump Celebrates Independence Day with B-2 Flyover and Signs Controversial Legislation
Boris Johnson Urges Conservatives to Ignore Farage
SNP Ordered to Update Single-Sex Space Guidance Within Days
Starmer Set to Reject Calls for Wealth Taxes
Stolen Century-Old Rolls-Royce Recovered After Hotel Theft
Macron Presses Starmer to Recognise Palestinian State
Labour Delayed Palestine Action Ban Over Riot Concerns
Swinney’s Tax Comments ‘Offensive to Scots’, Say Tories
High Street Retailers to Enforce Bans on Serial Shoplifters
Music Banned by Henry VIII to Be Performed After 500 Years
Steve Coogan Says Working Class Is Being ‘Ethnically Cleansed’
Home Office Admits Uncertainty Over Visa Overstayer Numbers
JD Vance Questions Mandelson Over Reform Party’s Rising Popularity
Macron to Receive Windsor Carriage Ride in Royal Gesture
Labour Accused of ‘Hammering’ Scots During First Year in Power
BBC Head of Music Stood Down Amid Bob Vylan Controversy
Corbyn Eyes Hard-Left Challenge to Starmer’s Leadership
London Tube Trains Suspended After Major Fire Erupts Nearby
Richard Kemp: I Felt Safer in Israel Under Attack Than in the UK
Cyclist Says Police Cited Human Rights Act for Riding No-Handed
China’s Central Bank Consults European Peers on Low-Rate Strategies
AI Raises Alarms Over Long-Term Job Security
Saudi Arabia Maintains Ties with Iran Despite Israel Conflict
Musk Battles to Protect Tesla Amid Trump Policy Threats
Air France-KLM Acquires Majority Stake in Scandinavian Airlines
UK Educators Sound Alarm on Declining Child Literacy
Shein Fined €40 Million in France Over Misleading Discounts
Brazil’s Lula Visits Kirchner During Argentina House Arrest
Trump Scores Legislative Win as House Passes Tax Reform Bill
Keir Starmer Faces Criticism After Rocky First Year in Power
DJI Launches Heavy-Duty Coaxial Quadcopter with 80 kg Lift Capacity
U.S. Senate Approves Major Legislation Dubbed the 'Big Beautiful Bill'
Largest Healthcare Fraud Takedown in U.S. History Announced by DOJ
Poland Implements Border Checks Amid Growing Migration Tensions
Political Dispute Escalates Between Trump and Musk
Emirates Airline Expands Market Share with New $20 Million Campaign
Amazon Reaches Milestone with Deployment of One Millionth Robot
US Senate Votes to Remove AI Regulation Moratorium from Domestic Policy Bill
Yulia Putintseva Calls for Spectator Ejection at Wimbledon Over Safety Concerns
Jury Deliberations in Diddy Trial Yield Partial Verdict in Serious Criminal Charges
House Oversight Committee Subpoenas Former Jill Biden Aide Amid Investigation into Alleged Concealment of President Biden's Cognitive Health
King Charles Plans Significant Role for Prince Harry in Coronation
Two Chinese Nationals Arrested for Espionage Activities Against U.S. Navy
Amazon Reaches Major Automation Milestone with Over One Million Robots
Extreme Heat Wave Sweeps Across Europe, Hitting Record Temperatures
Meta Announces Formation of Ambitious AI Unit, Meta Superintelligence Labs
Robots Compete in Football Tournament in China Amid Injuries
×